Pediatric Cancer Clinical Trials

32 studies are recruiting for pediatric cancer in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Studies, page 2

1. Beat Childhood Cancer Specimen Banking and Data Registry

   This is an observational data registry study of pediatric cancer patients at participating Beat Childhood Cancer Consortium sites involving specimen banking and data collection.

   Stage

   Not phased

   Ages

   Any age

   Site

   Arkansas Children's Hospital, Little Rock, Arkansas

   Locations

   18 in total

   Run by

   Giselle Sholler

   See if you can join NCT04715178 on ClinicalTrials.gov

2. Targeted Therapy to Increase RAI Uptake in Metastatic DTC

   Papillary thyroid cancer (PTC) is a common type of differentiated thyroid cancer (DTC) in children and represents the second most common cancer in adolescent females. Recently targeted drugs that block many of the genetic drivers of DTC have become available. While Investigators know that these dru…

   Stage

   Not phased

   Ages

   0 and older

   Site

   University of California San Francisco, San Francisco, California

   Locations

   9 in total

   Run by

   Children's Hospital of Philadelphia

   See if you can join NCT05024929 on ClinicalTrials.gov

3. Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer

   Papillary thyroid cancer (PTC) is the most common form of differentiated thyroid cancer (DTC). The traditional first line treatment for patients with advanced DTC after surgical resection is radioactive iodine (RAI) therapy. However, less than a quarter of patients with lung metastases will achieve…

   Stage

   Phase 2

   Ages

   2 to 99

   Site

   University of California, San Francisco, San Francisco, California

   Locations

   5 in total

   Run by

   Children's Hospital of Philadelphia

   See if you can join NCT05783323 on ClinicalTrials.gov

4. Childhood Cancer Predisposition Study (CCPS)

   The Childhood Cancer Predisposition Study (CCPS) is a multi-center, longitudinal, observational study that will collect clinical and biological data and specimens from children with a cancer predisposition syndromes (CPS) and their relatives. The central hypothesis is that studying individuals at h…

   Stage

   Not phased

   Ages

   Any age

   Site

   Children's Healthcare of Atlanta (CHOA), Atlanta, Georgia

   Locations

   7 in total

   Run by

   Emory University

   See if you can join NCT04511806 on ClinicalTrials.gov

5. Improving Communication Between AYA Oncology Patients and Clinicians: A Patient-Centered Intervention

   The overarching goal is to develop and demonstrate proof-of-concept of ReSPECT (Reproductive and Sexual Health Patient Education and Communication Tool), a multi-modal communication intervention to improve adolescent and young adult (AYA)- clinician sexual and reproductive health (SRH) communicatio…

   Stage

   Not phased

   Ages

   15 to 25

   Site

   Connecticut Children's Medical Center, Hartford, Connecticut

   Run by

   Connecticut Children's Medical Center

   See if you can join NCT06982066 on ClinicalTrials.gov

6. Cardiotoxicity Assessment Through Comprehensive Heart Imaging to Predict Heart Failure

   Anthracycline chemotherapies (e.g. doxorubicin, daunorubicin) are commonly given to treat pediatric cancer, and carry a risk of cardiotoxicity. Over the long term, children who receive these therapies have an increased risk of heart failure and early cardiovascular death. However, current strategie…

   Stage

   Not phased

   Ages

   13 to 39

   Site

   Rady Children's Hospital, San Diego, California

   Run by

   Hari Narayan

   See if you can join NCT04262830 on ClinicalTrials.gov

7. Feasibility/Acceptability of Attentional-Control Training in Survivors

   This is a multicenter pilot randomized controlled trial, with an active control condition, of the feasibility, acceptability, and preliminary efficacy of EndeavorRx in a cohort of survivors of acute lymphoblastic leukemia or brain tumor ages 8-16 who are > 1 year from the end of therapy.

   Stage

   Not phased

   Ages

   8 to 16

   Site

   Children's National Hospital, Washington D.C., District of Columbia

   Run by

   Children's National Research Institute

   See if you can join NCT05528939 on ClinicalTrials.gov